Iron mobilization by succinylacetone methyl ester in rats. A model study for hereditary tyrosinemia and porphyrias characterized by 5-Aminolevulinic acid overload

References

• Mitchell G.A., Lambert M.A., Tanguay R.M. Hereditary tyrosinemia. The Metabolic Basis of Inherited Diseases7th edn., C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle. McGraw-Hill book Co., New York 1995; 1077–1106, In
   Google Scholar
• Phaneuf D., Hadchouel M., Tanguay R.M., Bréchot C., Ferry N. Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer. Biochemical Biophysical Research Communications 1995; 208: 957–963
   PubMedGoogle Scholar
• Goldsmith L.A., LaBerge C. Tyrosinemia and related disorders. The Metabolic Basis of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle. McGraw-Hill, New York 1989; I: 547–562, In
   Google Scholar
• Berger R., van Faassen H., Smith G.P.A. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia. Clinica Chimica Acta 1983; 134: 129–141
   PubMedGoogle Scholar
• Ebert S.P., Hess R.A., Frykholm B.C., Tschudy D.P. Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and δ-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells. Biochemical Biophysical Research Communications 1979; 88: 1382–1390
   PubMed Web of Science ®Google Scholar
• Hindmarsh J.T. The porphyrias: recent advances. Clinical Chemistry 1986; 32: 1255–1263
   PubMedGoogle Scholar
• Monteiro H.P., Abdalla D.S.P., Faljoni-Alário A., Bechara E.J.H. Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and δ-aminolevulinic acid. Biochim. Biophys. Acta 1986; 881: 100–106
   PubMed Web of Science ®Google Scholar
• Bechara E.J.H., Medeiros M.H.G., Monteiro H.P., Hermes-Lima M., Pereira B., Demasi M., Costa C.A., Abdalla D.S.P., Onuki J., Wendel C.M.A., DiMascio P. A free radical hypothesis of lead poisoning and inborn porphyrias associated with 5-aminolevulinic acid overload. Química Nova 1993; 16: 385–392
   Google Scholar
• Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radical Biology and Medicine 1996; 20: 553–566
   PubMed Web of Science ®Google Scholar
• Bechara E.J.H., Medeiros M.H.G., Catalani L.H., Soares C.H.L., Monteiro H.P., Abdalla D.S.P., Cristoff M., Hermes-Lima M., Pereira B., Demasi M., Nantes I.L., Costa C.A., Rocha M.E.M., DiMascio P., Wendel C.M.A., Onuki J., Penatti C.A.A., Pinto A.P. Enolizable carbonyl and imino metabolites may act as endogenous sources of reactive oxygen species. Ciência e Cultura 1995; 47: 346–357
   Google Scholar
• Carvalho H., Bechara E.J.H., Meneghini R., Demasi M. The heme precursor δ-aminolevulinic acid induces activation of cytosolic iron regulatory protein 1. Biochemical Journal 1997; 328: 827–832
   PubMedGoogle Scholar
• Fraga C.G., Onuki J., Lusesoli F., Bechara E.J.H., DiMascio P. 5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydroxy-2′-deoxyguanosine in DNA. Carcinogenesis 1994; 15: 2241–2244
   PubMed Web of Science ®Google Scholar
• Morehouse K.M., Moreno S.N.J., Mason R.P. The one-electron reduction of uroporphyrin I by hepatic microsomes. Archives of Biochemistry and Biophysics 1987; 257: 276–284
   PubMed Web of Science ®Google Scholar
• Battle A.M.del C. Porphyrins, porphyrias, cancer and photodynamic therapy — a model for carcinogenesis. Journal of Photochemistry and Photobiology B.: Biology 1993; 20: 5–22
   PubMedGoogle Scholar
• Puy H., Deybach J.C., Bogdan A., Callebert J., Baumgartner M., Voisin P., Nordmann Y., Touitou Y. Increased δ-aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat. Journal of Clinical Investigation 1996; 97: 104–110
   PubMed Web of Science ®Google Scholar
• Tschudy D.P., Hess R.A., Frykholm B.C. Inhibition of δ-aminolevulinic acid dehydratase by 4,6-dioxoheptanoic acid. Journal of Biological Chemistry 1981; 256: 9915–9923
   PubMed Web of Science ®Google Scholar
• Costa C.A., Trivelato G.C., Demasi M., Bechara E.J.H. Determination of 5-aminolevulinic acid in blood plasma, tissues and cell cultures by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B: Biomedical Science Applications 1997; 695: 245–250
   PubMedGoogle Scholar
• Lindroth P., Mopper K. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Analytical Chemistry 1979; 51: 1667–1674
   Web of Science ®Google Scholar
• Dexter D.T., Carayon A., Vidailhet M., Ruberg M., Agid F., Agid Y., Lees A.J., Wells F.R., Jenner P., Marsden C.D. Decreased ferritin levels in brain in Parkinson's disease. Journal of Neurochemistry 1990; 55: 16–20
   PubMed Web of Science ®Google Scholar
• Bralet J., Schreiber L., Bouvier C. Effects of acidosis and anoxia on iron delocalization from brain homogenates. Biochemical Pharmacology 1992; 43: 979–983
   PubMed Web of Science ®Google Scholar
• Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified protein. Methods in Enzymology 1990; 186: 464–502
   PubMed Web of Science ®Google Scholar
• Fraga C.G., Leibovitz B.E., Tappel A.L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radical Biology and Medicine 1988; 4: 155–161
   PubMed Web of Science ®Google Scholar
• Flohé L., Ötting F. Superoxide dismutase assays. Methods in Enzymology 1984; 105: 93–104
   PubMed Web of Science ®Google Scholar
• Crapo D.J., McCord J.M., Fridovich I. Preparation and assay of superoxide dismutases. Methods in Enzymology 1978; 53: 382–393
   PubMedGoogle Scholar
• Lowry O.H., Rosebrough H.J., Farr A.C., Randal R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Adams M.L., Ostapiuk I., Grasso J.A. The effects of inhibition of heme synthesis on the intracellular localization of iron in rat reticulocytes. Biochimica Biophysica Acta 1989; 1012: 243–253
   PubMed Web of Science ®Google Scholar
• Oteiza P.I., Kleinman C.G., Demasi M., Bechara E.J.H. 5-Aminolevulinic acid induces iron release from ferritin. Archives of Biochemistry and Biophysics 1995; 316: 607–611
   PubMed Web of Science ®Google Scholar
• Cairo G., Tacchini L., Pogliagihi G., Anzon E., Tomasi A., Bernelli-Zazzera A. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the “free” iron pool. Journal of Biological Chemistry 1995; 270: 700–703
   PubMed Web of Science ®Google Scholar
• Demasi M., Penatti C.A., DeLucia R., Bechara E.J.H. The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. Free Radical Biology and Medicine 1996; 20: 291–299
   PubMed Web of Science ®Google Scholar
• Pereira B., Curi R., Kokubun E., Bechara E.J.H. 5-Aminolevulinic acid-induced alterations of oxidative metabolism in sedentary and exercise-trained rats. Journal of Applied Physiology 1992; 72: 226–230
   PubMed Web of Science ®Google Scholar
• Demasi M., Costa C.A., Pascual C., Llesuy S., Bechara E.J.H. Oxidative tissue response promoted by 5-aminolevulinic acid promptly induces the increase of plasma antioxidant capacity. Free Radical Research 1997; 26: 235–243
   PubMed Web of Science ®Google Scholar
• Onuki J., Medeiros M.H.G., Bechara E.J.H., DiMascio P. 5-Aminolevulinic acid induces single-strand breaks in plasma pBR322 DNA in the presence of Fe2+ ions. Biochimica Biophysica Acta 1994; 1225: 259–263
   PubMed Web of Science ®Google Scholar
• Oteiza P.I., Bechara E.J.H. 5-Aminolevulinic acid induces lipid-peroxidation in cardiolipin-rich liposomes. Archives of Biochemistry and Biophysics 1993; 305: 282–287
   PubMed Web of Science ®Google Scholar
• Vercesi A.E., Castiho R.F., Meinicke A.R., Valle V.G.R., Hermes-Lima M., Bechara E.J.H. Oxidative damage of mitochondria induced by 5-aminolevulinic acid: Role of Ca2+ and membrane protein thiols. Biochimica Biophysica Acta 1994; 1188: 86–92
   PubMed Web of Science ®Google Scholar
• Eisenstein R.S., Garcia-Mayol D., Pettingell W., Munro H.N. Regulation of ferritin and heme oxygenase synthesis in rat fibroblast by different forms of iron. Proceedings of the National Academy of Sciences USA 1991; 88: 688–692
   PubMed Web of Science ®Google Scholar
• Monteiro H.P., Abdalla D.S.P., Augusto O., Bechara E.J.H. Free radical generation during 5-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinopathies. Archives of Biochemistry and Biophysics 1989; 271: 206–216
   PubMed Web of Science ®Google Scholar
• Hermes-Lima M., Valle V.G.R., Vercesi A.E., Bechara E.J.H. Damage to rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning. Biochimica Biophysica Acta 1991; 1056: 57–63
   PubMed Web of Science ®Google Scholar
• Hermes-Lima M., Castilho R.F., Valderez G.R., Bechara E.J.H., Vercesi A.E. Calcium-dependent mitochondrial oxidative damage promoted by 5-aminolevulinic acid. Biochimica Biophysica Acta 1992; 1180: 201–206
   PubMedGoogle Scholar
• Penatti C.A.A., Bechara E.J.H., Demasi M. δ-Aminolevulinic acid-induced synaptosomal Ca2+ uptake and mitochondrial permeabilization. Archives of Biochemistry and Biophysics 1996; 335: 53–60
   PubMedGoogle Scholar
• Hermes-Lima M. How do ca2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria?. Free Radical Biology and Medicine 1995; 19: 381–390
   PubMedGoogle Scholar
• Biempica L., Kosower N., Ma M.H., Goldfisher S. Cytochemical and ultrastructural studies of liver in acute intermittent porphyria and porphyria cutanea tarda. Arch. Pathol. 1974; 98: 336–343
   PubMedGoogle Scholar
• Lithner F., Wetterberg L. Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Medica Scananavia 1984; 215: 271–274
   PubMedGoogle Scholar
• Kauppinen R., Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. British Journal of Cancer 1988; 57: 117–120
   PubMed Web of Science ®Google Scholar
• Wyss P.A., Boynton S.B., Chu J., Spencer R.F., Roth K.S. Physiological basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat. Clinical Science 1992; 83: 81–87
   PubMed Web of Science ®Google Scholar
• Wyss P.A., Boynton S., Chu J., Roth K.S. Tissue distribution of succinylacetone in the rat in vivo: a possible basis for neurotoxicity in hereditary infantile tyrosinemia. Biochimica Biophysica Acta 1993; 1182: 323–328
   PubMedGoogle Scholar
• Jorquera R., Tanguay R.M. The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. Biochemical and Biophysical Research Communications 1997; 232: 42–48
   PubMedGoogle Scholar
• Endo F., Kubo S., Awata H., Kiwaki K., Katoh H., Kanegae Y., Saito I., Miyazaki J.-I., Yamamoto T., Jackobs C., Hattori S., Matsuda I. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. Journal of Biological Chemistry 1997; 272: 24426–24432
   PubMed Web of Science ®Google Scholar
• Muta K., Krantz S.B. Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells. Journal of Cellular Physiology 1995; 163: 38–50
   PubMed Web of Science ®Google Scholar
• Carneiro R.C.G., Reiter R.J. Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerrebellum, cortex and hippocampus. Neuroscience 1998; 82: 293–299
   PubMed Web of Science ®Google Scholar
• Ercal N., Treratphan P., Hammond T.C., Mathews R.H., Grannemann N.H., Spitz D.R. In vivo indices if oxidative stress in lead exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radical Biology and Medicine 1996; 21: 157–161
   PubMed Web of Science ®Google Scholar